Nanobodies Market - Novo Nordisk A/S, Merck & Co., Inc., Merck KGaA, AbbVie, Inc., and C.H. Boehringer Sohn AG & Ko. KG.

Nanobodies are considered to be one of the best technology in the fields of research, diagnostics and therapy especially in cancer research. These technology was developed from antigen binding fragments, originating from Camelid heavy-chain antibodies. These molecules do not have light chains, which is an essential part of antibody found in humans. Based on the above finding, nanobodies molecule containing single-domain only were developed, and these molecules contain functional and structural properties similar to heavy chain antibodies. These molecules have several advantages as compared to the conventional antibodies such as small-size, nano to picomolar affinities, and multiple route of administration. Ablynx, which is acquired by Sanofi S.A., is one of the leading company in this market.

Get PDF Brochure with COVID19 Impact Analysis @ https://www.coherentmarketinsights.com/insight/request-pdf/1680

Nanobodies Market Drivers

Currently, no products are available in the market, but there are multiple products in the pipeline including few in very late stage of clinical trials. For instance, marketing authorization application for Caplacizumab for the treatment of acquired thrombotic thrombocytopenic purpura (aTTP) has been submitted to European Medicine Agency (EMA) in February 2017. The product, Caplacizumab, is expected to be launched in Europe in 2018. Moreover, the company, Ablynx, is expected to file for biologic license agreement to the U.S. Food and Drug Administration (FDA) in 2018, and is expected to launch this product in U.S. in 2019. Both, Europe and U.S. are the key markets for any biologics including monoclonal antibodies and are expected to be the high revenue generating market for nanobodies. Hence, approval by regulatory bodies in Europe and U.S. to Caplacizumab in very near future (i.e. 2018, 2019) is expected to drive the growth of global nanobodies market. As per the company, Ablynx, estimates the product has potential to generate more than US$ 1 Bn. Furthermore, there are multiple products in early stage of clinical development i.e. preclinical, phase 0, and phase 1. Ablynx alone had 8 products in clinical development phase (i.e. phase 0 to phase 3) and overall 45 products in pipeline as of March 2017.

Purchase This Premium Report Here With Discounted Price (Flat US $1000 Off) – https://www.coherentmarketinsights.com/promo/buynow/1680

Major Players Are: Novo Nordisk A/S, Merck & Co., Inc., Merck KGaA, AbbVie, Inc., and C.H. Boehringer Sohn AG & Ko. KG.

The report contains parts that feature the accompanying about the business that can be conveyed

Analysis of market effect factors including technical progress / risk, consumer needs / changing customer preferences and economic / political environmental changes
Nanobodies Market forecast including production, consumption, import and export forecast by type, applications and region
Nanobodies Market dynamics, regulation and trend analysis - market dynamics, regulation scenario, industry trend, mergers and acquisitions, new system introduction / approval, value chain analysis, porter analysis and pest control analysis
Global Nanobodies Market by Region
Manufacturer's Nanobodies Market competition, including production, share, yield, average price, production base distribution, sales area and product type
Nanobodies Market manufacturer profiles / analysis, including the basic information of the company, the production base and its competitors
Nanobodies Analysis of market production costs, including key raw materials and key raw material suppliers
Industry chain, procurement strategy and downstream purchasers, including downstream sourcing and downstream purchasing
Marketing strategy analysis, distributors / dealers including marketing channel, market positioning and list of distributors / dealers
Research results and conclusion

Contact Us

Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Phone: US +12067016702 / UK +4402081334027
Email: sales@coherentmarketinsights.com

About Coherent Market Insights

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Visit Our Blog For More Related Reports: https://www.coherentmarketinsights.com/blog

&

Latest Insights: https://www.coherentmarketinsights.com/latest-insights

This release was published on openPR.